LIGAND PHARMACEUTICALS financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Sep 2026Filed 30/10/2026 | Jun 2026Filed 30/10/2026 | Mar 2026Filed 30/10/2026 | Sep 2025Filed 30/10/2026 | Jun 2025Filed 07/08/2026 | Mar 2025Filed 08/05/2026 | Sep 2024Filed 07/11/2025 | Jun 2024Filed 07/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $79 | $64 | $52 | $115 | $48 | $45 | $52 | $42 | |
| −$28 | $49 | −$13 | $117 | $4.8 | −$42 | −$7.2 | −$52 | |
| −$1.43 | $2.22 | −$0.67 | $5.68 | $0.24 | −$2.21 | −$0.39 | −$2.88 | |
| 20 | 22 | 20 | 21 | 20 | 19 | 18 | 18 |
Trend